blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1589934

EP1589934 - CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.07.2016
Database last updated on 23.04.2024
Most recent event   Tooltip29.07.2016No opposition filed within time limitpublished on 31.08.2016  [2016/35]
Applicant(s)For all designated states
CORIXA CORPORATION
Corporation Service Company
2711 Centerville Road, Suite 400
Wilmington, DE 19808 / US
[2015/39]
Former [2005/44]For all designated states
CORIXA CORPORATION
1900 9th Avenue Suite 1100
Seattle, WA 98101 / US
Inventor(s)01 / JOHNSON, David, A.
121 Woodland Way
Hamilton, MT 59840 / US
 [2005/44]
Representative(s)Wells, Andrew, et al
HGF Limited
4th Floor, Merchant Exchange
17-19 Whitworth Street West
Manchester M1 5WG / GB
[2015/39]
Former [2014/07]Wells, Andrew, et al
Harrison Goddard Foote LLP
4th Floor, Merchant Exchange
17-19 Whitworth Street West
Manchester M1 5WG / GB
Former [2012/38]Harrison Goddard Foote
4th Floor
Merchant Exchange
17-19 Whitworth Street West
Manchester M1 5WG / GB
Former [2005/44]Harrison Goddard Foote
Belgrave Hall Belgrave Street
Leeds LS2 8DD / GB
Application number, filing date04700403.106.01.2004
[2005/44]
WO2004US00377
Priority number, dateUS20030438585P06.01.2003         Original published format: US 438585 P
[2005/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004062599
Date:29.07.2004
Language:EN
[2004/31]
Type: A2 Application without search report 
No.:EP1589934
Date:02.11.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 29.07.2004 takes the place of the publication of the European patent application.
[2005/44]
Type: B1 Patent specification 
No.:EP1589934
Date:23.09.2015
Language:EN
[2015/39]
Search report(s)International search report - published on:US04.01.2007
(Supplementary) European search report - dispatched on:EP05.08.2011
ClassificationIPC:C07H15/04
[2011/36]
CPC:
C07H13/04 (EP); C07H15/04 (EP,KR); A61P31/00 (EP);
A61P31/04 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/04 (EP); A61P37/06 (EP);
A61P37/08 (EP); A61P43/00 (EP); C07H11/04 (EP);
C07H5/02 (EP) (-)
Former IPC [2007/10]A61K31/7008
Former IPC [2005/44]A61K7/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2015/39]
Former [2005/44]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:BESTIMMTE AMINOALKYL-GLUCOSAMINID-PHOSPHATVERBINDUNGEN UND IHRE VERWENDUNG[2005/44]
English:CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE[2005/44]
French:COMPOSÉS D'AMINOALKYLE GLUCOSAMINIDE PHOSPHATE ET LEUR UTILISATION[2015/08]
Former [2005/44]COMPOSES D'AMINOALKYLE GLUCOSAMINIDE PHOSPHATE ET LEUR UTILISATION
Entry into regional phase05.08.2005National basic fee paid 
05.08.2005Search fee paid 
05.08.2005Designation fee(s) paid 
05.08.2005Examination fee paid 
Examination procedure05.08.2005Examination requested  [2005/44]
10.10.2011Amendment by applicant (claims and/or description)
27.01.2012Despatch of a communication from the examining division (Time limit: M04)
21.05.2012Reply to a communication from the examining division
29.04.2014Despatch of a communication from the examining division (Time limit: M06)
06.11.2014Reply to a communication from the examining division
20.01.2015Communication of intention to grant the patent
30.03.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
16.04.2015Communication of intention to grant the patent
14.08.2015Fee for grant paid
14.08.2015Fee for publishing/printing paid
14.08.2015Receipt of the translation of the claim(s)
Divisional application(s)EP15161799.0  / EP2940028
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.01.2012
Opposition(s)24.06.2016No opposition filed within time limit [2016/35]
Fees paidRenewal fee
09.01.2006Renewal fee patent year 03
05.01.2007Renewal fee patent year 04
08.01.2008Renewal fee patent year 05
07.01.2009Renewal fee patent year 06
07.01.2010Renewal fee patent year 07
06.01.2011Renewal fee patent year 08
06.01.2012Renewal fee patent year 09
08.01.2013Renewal fee patent year 10
08.01.2014Renewal fee patent year 11
08.01.2015Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0134617  (CORIXA CORP [US], et al) [X] 1-37 * the whole document *;
 [A]  - PERSING, DAVID H. ET AL, "Taking toll: lipid A mimetics as adjuvants and immunomodulators", TRENDS IN MICROBIOLOGY , 10(10, SUPPL.), S32-S37 CODEN: TRMIEA; ISSN: 0966-842X, (2002), XP009067296 [A] 1-37

DOI:   http://dx.doi.org/10.1016/S0966-842X(02)02426-5
International search[Y]US5593969  (KAMIREDDY BALREDDY [US], et al);
 [Y]US6355257  (JOHNSON DAVID A [US], et al)
Examination   - H. G. BAZIN ET AL, "The "etheral" nature of TRL4 agonism and antagonism in the AGP class of lipid A mimetics", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (2008), vol. 18, pages 5350 - 5354
by applicantUS6008200
 US4436727
 US4603112
 US4683195
 US4683202
 US4751180
 GB2200651
 US4769330
 GB2202328
 US4777127
 US4790824
 WO8810315
 US4800159
 WO8901973
 WO8903429
 EP0320308
 WO8906700
 EP0329822
 US4866034
 US4877611
 US4883750
 EP0345242
 US4912094
 US4935233
 US4987237
 WO9102805
 US5017487
 WO9112882
 US5064413
 WO9118926
 WO9201070
 WO9203545
 US5128326
 US5139941
 EP0500799
 US5145684
 US5151254
 US5173414
 WO9303769
 US5219740
 US5312335
 WO9420078
 WO9423701
 US5383851
 US5399163
 US5399363
 US5466468
 WO9602555
 WO9606638
 US5505947
 US5520639
 US5530113
 US5543158
 US5552157
 US5565213
 US5567434
 US5580579
 WO9638591
 US5584807
 US5633234
 US5641515
 US5643576
 US5679377
 US5725871
 US5738868
 US5756353
 US5780045
 US5792451
 US5795587
 US5804212
 WO9850399
 US5843723
 US5846796
 US5856462
 US5865796
 WO9912154
 WO9920253
 US5912015
 US5916597
 WO9933488
 WO9952549
 US5989463
 US5993412
 US6008035
 US6010478
 US6015686
 US6015694
 US6113918
 WO0134617
 US6303347
 WO0190129
 WO0212258
 US6355251
    - JOHNSON ET AL., JMED CHEM, (1999), vol. 42, pages 4640 - 4649
    - ULRICH; MYERS, ULRICH; MYERS, POWELL AND NEWMAN, Vaccine Design: The Subunit and Adjuvant Approach, PLENUM, (1995), pages 495 - 524
    - SEYDEL ET AL., IMMUNOBIOL, (1993), vol. 187, no. 3-5, pages 191 - 211
    - ERWIN; MUNFORD, J BIOL CHEM, (1990), vol. 265, no. 27, pages 16444 - 16449
    - CHRIST ET AL., SCIENCE, (1995), vol. 268, pages 80 - 83
    - LIEN ET AL., J BIOL CHEM, (2001), vol. 276, no. 3, pages 1873 - 1880
    - BERGE, S.M. ET AL., "Pharmaceutical Salts", JOURNAL OF PHARMACEUTICAL SCIENCE, (1977), vol. 66, pages 1 - 19
    - JOHNSON ET AL., J. MED. CHEM., (1999), vol. 42, pages 4640 - 4649
    - JOHNSON ET AL., BIOORG. MED. CHEM. LETT., (1999), vol. 9, pages 2273 - 2278
    - PAUL, Fundamental Immunology, 3rd ed., RAVEN PRESS, (1993), pages 243 - 247
    - MARATEA ET AL., GENE, (1985), vol. 40, pages 39 - 46
    - MURPHY ET AL., PROC. NATL. ACAD. SCI. USA, (1986), vol. 83, pages 8258 - 8262
    - STOUTE ET AL., NEW ENGL. J. MED., (1997), vol. 336, pages 86 - 91
    - SKEIKY ET AL., INFECTION AND IMMUN., (1999), vol. 67, pages 3998 - 4007
    - GENE, (1986), vol. 43, pages 265 - 292
    - BIOTECHNOLOGY, (1992), vol. 10, pages 795 - 798
    - MERRIFIELD, J. AM. CHEM. SOC., (1963), vol. 85, pages 2149 - 2146
    - SCHENA ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, pages 10614 - 10619
    - HELLER ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 2150 - 2155
    - LAGERSTROM ET AL., PCR METHODS APPLIC., (1991), vol. 1, pages 111 - 19
    - PARKER ET AL., NUCL. ACIDS. RES., (1991), vol. 19, pages 3055 - 60
    - CARUTHERS, M. H. ET AL., NUCL. ACIDS RES. SYMP. SER., (1980), pages 215 - 223
    - HORN, T. ET AL., NUCL. ACIDS RES. SYMP. SER., (1980), pages 225 - 232
    - LOGAN, J.; SHENK, T., PROC. NATL. ACAD. SCI., (1984), vol. 81, pages 3655 - 3659
    - SCHARF, D. ET AL., RESULTS PROBL. CELL DIFFER., (1994), vol. 20, pages 125 - 162
    - MADDOX, D. E. ET AL., J. EXP. MED., (1983), vol. 158, pages 1211 - 1216
    - LANGER, SCIENCE, (1990), vol. 249, pages 1527 - 1533
    - SEFTON, CRC CRIT. REF. BIOMED. ENG., (1987), vol. 14, page 10
    - BUSCHWALD ET AL., SURGERY, (1980), vol. 88, page 507
    - SAUDEK ET AL., N. ENGL. J. MED., (1989), vol. 321, page 574
    - RANGER; PEPPAS, J. MACROMOL. SCI. REV. MACROL. CHEM., (1983), vol. 23, page 61
    - LEVY ET AL., SCIENCE, (1985), vol. 228, page 190
    - DURING ET AL., ANN. NEUROL., (1989), vol. 25, page 51
    - HOWARD ET AL., J. NEUROSURG., (1989), vol. 7 1, page 105
    - GOODSON, Medical Applications of Controlled Release, (1984), vol. 2, pages 115 - 138
    - ROLLAND, CRIT. REV. THERAP. DRUG CARRIER SYSTEMS, (1998), vol. 15, pages 143 - 198
    - MILLER; ROSMAN, BIOTECHNIQUES, (1989), vol. 7, pages 980 - 990
    - MILLER, A. D., HUMAN GENE THERAPY, (1990), vol. 1, pages 5 - 14
    - SCARPA ET AL., VIROLOGY, (1991), vol. 180, pages 849 - 852
    - BURNS ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 8033 - 8037
    - BORIS-LAWRIE; TEMIN, CUR. OPIN. GENET. DEVELOP, (1993), vol. 3, pages 102 - 109
    - HAJ-AHMAD; GRAHAM, J. VIROL., (1986), vol. 57, pages 267 - 274
    - BETT ET AL., J. VIROL., (1993), vol. 67, pages 5911 - 5921
    - MITTEREDER ET AL., HUMAN GENE THERAPY, (1994), vol. 5, pages 717 - 729
    - SETH ET AL., J. VIROL, (1994), vol. 68, pages 933 - 940
    - BARR ET AL., GENE THERAPY, (1994), vol. 1, pages 51 - 58
    - BERKNER, K. L., BIOTECHNIQUES, (1988), vol. 6, pages 616 - 629
    - RICH ET AL., HUMAN GENE THERAPY, (1993), vol. 4, pages 461 - 476
    - LEBKOWSKI ET AL., MOLEC. CELL. BIOL., (1988), vol. 8, pages 3988 - 3996
    - VINCENT ET AL., Vaccines, COLD SPRING HARBOR LABORATORY PRESS, (1990), vol. 90
    - CARTER, B. J., CURRENT OPINION IN BIOTECHNOLOGY, (1992), vol. 3, pages 533 - 539
    - MUZYCZKA, N., CURRENT TOPICS IN MICROBIOL. AND IMMUNOL., (1992), vol. 158, pages 97 - 129
    - KOTIN, R. M., HUMAN GENE THERAPY, (1994), vol. 5, pages 793 - 801
    - SHELLING; SMITH, GENE THERAPY, (1994), vol. 1, pages 165 - 169
    - ZHOU ET AL., J. EXP. MED., (1994), vol. 179, pages 1867 - 1875
    - ELROY-STEIN; MOSS, PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, pages 6743 - 6747
    - FUERST ET AL., PROC. NATL. ACAD. SCI. USA, (1986), vol. 83, pages 8122 - 8126
    - MICHAEL ET AL., J. BIOL. CHEM., (1993), vol. 268, pages 6866 - 6869
    - WAGNER ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 6099 - 6103
    - FISHER-HOCH ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 317 - 321
    - FLEXNER ET AL., ANN. N.Y. ACAD. SCI., (1989), vol. 569, pages 86 - 103
    - FLEXNER ET AL., VACCINE, (1990), vol. 8, pages 17 - 21
    - BERKNER, BIOTECHNIQUES, (1988), vol. 6, pages 616 - 627
    - ROSENFELD ET AL., SCIENCE, (1991), vol. 252, pages 431 - 434
    - KOLLS ET AL., PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, pages 215 - 219
    - KASS-EISLER ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 11498 - 11502
    - GUZMAN ET AL., CIRCULATION, (1993), vol. 88, pages 2838 - 2848
    - GUZMAN ET AL., CIR. RES., (1993), vol. 73, pages 1202 - 1207
    - ULMER ET AL., SCIENCE, (1993), vol. 259, pages 1745 - 1749
    - COHEN, SCIENCE, (1993), vol. 259, pages 1691 - 1692
    - MOSMANN; COFFMAN, ANN. REV. IMMUNOL., (1989), vol. 7, pages 145 - 173
    - SATO ET AL., SCIENCE, (1996), vol. 273, page 352
    - MATHIOWITZ ET AL., NATURE, (19970327), vol. 386, no. 6623, pages 410 - 4
    - HWANG ET AL., CRIT REV THER DRUG CARRIER SITS, (1998), vol. 15, no. 3, pages 243 - 84
    - "pages 1035-1038 and 1570-1580", Remington's Pharmaceutical Sciences, 15th ed., pages 1035 - 1580
    - TAKENAGA ET AL., J CONTROLLED RELEASE, (19980302), vol. 52, no. 1-2, pages 81 - 7
    - LASIC, TRENDS BIOTECHNOL, (199807), vol. 16, no. 7, pages 307 - 21
    - TAKAKURA, NIPPON RINSHO, (199803), vol. 56, no. 3, pages 691 - 5
    - CHANDRAN ET AL., INDIAN J EXP BIOL., (199708), vol. 35, no. 8, pages 801 - 9
    - MARGALIT, CRIT REV THER DRUG CARRIER SYST., (1995), vol. 12, no. 2-3, pages 233 - 61
    - RENNEISEN ET AL., J BIOL CHEM., (19900925), vol. 265, no. 27, pages 16337 - 42
    - MULLER ET AL., DNA CELL BIOL., (199004), vol. 9, no. 3, pages 221 - 9
    - QUINTANAR-GUERRERO ET AL., DRUG DEV IND PHARM., (199812), vol. 24, no. 12, pages 1113 - 28
    - COUVREUR ET AL., CRIT REV THER DRUG CARRIER SYST., (1988), vol. 5, no. 1, pages 1 - 20
    - MUHLEN ET AL., EUR J PHARM BIOPHARM., (199803), vol. 45, no. 2, pages 149 - 55
    - ZAMBAUX ET AL., J CONTROLLED RELEASE, (19980102), vol. 50, no. 1-3, pages 31 - 40
    - JAGER ET AL., ONCOLOGY, (2001), vol. 60, no. 1, pages 1 - 7
    - RENNER ET AL., ANN HEMATOL, (200012), vol. 79, no. 12, pages 651 - 9
    - SCHREIBER, H., FUNDAMENTAL IMMUNOLOGY, (1989), pages 923 - 955
    - KEEGAN ET AL., TETRAHEDRON: ASYMMETRY, (1996), vol. 7, no. 12, pages 3559 - 3564
    - BULUSU, JMED CHEM, (1992), vol. 35, no. 19, pages 3463 - 3469
    - JIANG ET AL., TETRAHEDRON, (2002), vol. 58, no. 43, pages 8833 - 8842
    - WATANABE ET AL., CARBOHYDR RES, (2001), vol. 332, no. 3, pages 257 - 277
    - JIANG., BIOORG MED CHEM LETT, (2002), vol. 12, no. 16, pages 2193 - 2196
    - WATANABE ET AL., CARBOHYDR RES, (2001), vol. 333, no. 3, pages 203 - 231
 WO1987US00880
 WO1989US01025
 US19990158585
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.